Cargando…
Haemoglobin oxygen affinity in patients with severe COVID‐19 infection
Autores principales: | Daniel, Yvonne, Hunt, Beverley J., Retter, Andrew, Henderson, Katherine, Wilson, Sarah, Sharpe, Claire C., Shattock, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283631/ https://www.ncbi.nlm.nih.gov/pubmed/32453889 http://dx.doi.org/10.1111/bjh.16888 |
Ejemplares similares
-
Abnormal concentration of porphyrins in serum from COVID‐19 patients
por: San Juan, Itxaso, et al.
Publicado: (2020) -
Real World Outcomes of Therapeutic Anticoagulation Use in Moderate COVID-19 Infection in Hospitalised Patients
por: Creeper, Katherine J., et al.
Publicado: (2022) -
Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19
por: Kundura, Lucy, et al.
Publicado: (2022) -
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
por: Abraham, Roshini S., et al.
Publicado: (2021) -
Palliative Care for Patients on Extracorporeal Membrane Oxygenation for COVID-19 Infection
por: Rao, Anirudh, et al.
Publicado: (2021)